BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim MJ, Kim JH, Chung JJ, Park MS, Lim JS, Oh YT. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology. 2003;228:719-726. [PMID: 12881583 DOI: 10.1148/radiol.2283020735] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Chan VO, Das JP, Gerstenmaier JF, Geoghegan J, Gibney RG, Collins CD, Skehan SJ, Malone DE. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist®)-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre. Ir J Med Sci 2012;181:499-509. [DOI: 10.1007/s11845-012-0805-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
2 Golfieri R, Marini E, Bazzocchi A, Fusco F, Trevisani F, Sama C, Mazzella G, Cavuto S, Piscaglia F, Bolondi L. Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT. Radiol Med. 2009;114:1239-1266. [PMID: 19697104 DOI: 10.1007/s11547-009-0439-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lee HY, Lee JM, Kim SH, Shin KS, Lee JY, Han JK, Choi BI. Detection and characterization of focal hepatic lesions by T2-weighted imaging: comparison of navigator-triggered turbo spin-echo, breath-hold turbo spin-echo, and HASTE sequences. Clinical Imaging 2009;33:281-8. [DOI: 10.1016/j.clinimag.2008.10.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
4 Roussel A, Petit E, Mallet L, Zins M. Splénose : intérêt de l’IRM avec injection de produit de contraste superparamagnétique. Journal de Radiologie 2008;89:1944-6. [DOI: 10.1016/s0221-0363(08)74792-9] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
5 Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, Kim YH, Han JK, Choi BI. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology 2015;275:97-109. [PMID: 25559230 DOI: 10.1148/radiol.14140690] [Cited by in Crossref: 237] [Cited by in F6Publishing: 224] [Article Influence: 33.9] [Reference Citation Analysis]
6 Thomay AA, Charpentier KP. Optimizing resection for "responding" hepatic metastases after neoadjuvant chemotherapy. J Surg Oncol 2010;102:1002-8. [PMID: 20734423 DOI: 10.1002/jso.21694] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Clasen S, Boss A, Schmidt D, Fritz J, Schraml C, Claussen C, Pereira P. Magnetic resonance imaging for hepatic radiofrequency ablation. European Journal of Radiology 2006;59:140-8. [DOI: 10.1016/j.ejrad.2006.04.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
8 Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. Cirrhosis-associated Hepatocellular Nodules: Correlation of Histopathologic and MR Imaging Features. RadioGraphics 2008;28:747-69. [DOI: 10.1148/rg.283055108] [Cited by in Crossref: 130] [Cited by in F6Publishing: 93] [Article Influence: 9.3] [Reference Citation Analysis]
9 Rempp H, Clasen S, Pereira PL. Image-based monitoring of magnetic resonance-guided thermoablative therapies for liver tumors. Cardiovasc Intervent Radiol. 2012;35:1281-1294. [PMID: 21785888 DOI: 10.1007/s00270-011-0227-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
10 Lee VS. Science to Practice: Can MR Imaging Replace Liver Biopsy for the Diagnosis of Early Fibrosis? Radiology 2006;239:309-10. [DOI: 10.1148/radiol.2392051872] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
11 Chen J, Si Y, Zhao K, Shi X, Bi W, Liu SE, Hua H. Evaluation of quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging in qualitative diagnosis of hepatic masses. BMC Med Imaging 2018;18:56. [PMID: 30587152 DOI: 10.1186/s12880-018-0299-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Mantatzis M, Kakolyris S, Amarantidis K, Karayiannakis A, Prassopoulos P. Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate? Eur Radiol 2009;19:1809-16. [PMID: 19238395 DOI: 10.1007/s00330-009-1327-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
13 Ariff B, Lloyd CR, Khan S, Shariff M, Thillainayagam AV, Bansi DS, Khan SA, Taylor-Robinson SD, Lim AK. Imaging of liver cancer. World J Gastroenterol 2009; 15(11): 1289-1300 [PMID: 19294758 DOI: 10.3748/wjg.15.1289] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
14 Park G, Kim YK, Kim CS, Yu HC, Hwang SB. Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine. Br J Radiol 2010;83:1010-6. [PMID: 20682591 DOI: 10.1259/bjr/66686028] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
15 Ward J. New MR techniques for the detection of liver metastases. Cancer Imaging 2006;6:33-42. [PMID: 16766267 DOI: 10.1102/1470-7330.2006.0007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
16 Rempp H, Loh H, Hoffmann R, Rothgang E, Pan L, Claussen CD, Clasen S. Liver lesion conspicuity during real-time MR-guided radiofrequency applicator placement using spoiled gradient echo and balanced steady-state free precession imaging. J Magn Reson Imaging. 2014;40:432-439. [PMID: 24677447 DOI: 10.1002/jmri.24371] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
17 Idee J, Port M, Raynal I, Schaefer M, Bonnemain B, Prigent P, Robert P, Robic C, Corot C. Superparamagnetic Nanoparticles of Iron Oxides for Magnetic Resonance Imaging Applications. In: Kumar CSSR, editor. Nanotechnologies for the Life Sciences. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2007. [DOI: 10.1002/9783527610419.ntls0108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
18 Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, Stoker J. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. Radiology 2005;237:123-31. [PMID: 16100087 DOI: 10.1148/radiol.2371042060] [Cited by in Crossref: 385] [Cited by in F6Publishing: 308] [Article Influence: 22.6] [Reference Citation Analysis]
19 Kim YK, Kwak HS, Han YM, Kim CS. Usefulness of Combining Sequentially Acquired Gadobenate Dimeglumine-Enhanced Magnetic Resonance Imaging and Resovist-Enhanced Magnetic Resonance Imaging for the Detection of Hepatocellular Carcinoma: Comparison With Computed Tomography Hepatic Arteriography and Computed Tomography Arterioportography Using 16-Slice Multidetector Computed Tomography. Journal of Computer Assisted Tomography 2007;31:702-11. [DOI: 10.1097/rct.0b013e31802d0b6b] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
20 Maurea S, Mainenti PP, Tambasco A, Imbriaco M, Mollica C, Laccetti E, Camera L, Liuzzi R, Salvatore M. Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media. Quant Imaging Med Surg. 2014;4:181-189. [PMID: 24914419 DOI: 10.3978/j.issn.2223-4292.2014.01.02] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
21 Sharma S, Camci C, Jabbour N. Management of hepatic metastasis from colorectal cancers: an update. J Hepatobiliary Pancreat Surg 2008;15:570-80. [PMID: 18987925 DOI: 10.1007/s00534-008-1350-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
22 Kanematsu M, Kondo H, Goshima S, Kato H, Tsuge U, Hirose Y, Kim MJ, Moriyama N. Imaging liver metastases: review and update. Eur J Radiol 2006;58:217-28. [PMID: 16406434 DOI: 10.1016/j.ejrad.2005.11.041] [Cited by in Crossref: 93] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
23 Kim MJ, Kim JH, Choi JY, Park SH, Chung JJ, Kim KW, Mitchell DG. Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions. AJR Am J Roentgenol 2006;187:W255-66. [PMID: 16928903 DOI: 10.2214/AJR.05.0706] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
24 Cresswell AB, Welsh FK, Rees M. A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy? HPB (Oxford). 2009;11:533-540. [PMID: 20495704 DOI: 10.1111/j.1477-2574.2009.00081.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
25 Xu LH, Cai SJ, Cai GX, Peng WJ. Imaging diagnosis of colorectal liver metastases. World J Gastroenterol 2011; 17(42): 4654-4659 [PMID: 22180707 DOI: 10.3748/wjg.v17.i42.4654] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
26 Quaia E, D'onofrio M, Bartolotta TV, Palumbo A, Midiri M, Calliada F, Rossi S, Mucelli RP. Characterization of Focal Liver Lesions. In: Quaia E, editor. Contrast Media in Ultrasonography. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 125-66. [DOI: 10.1007/3-540-27214-3_11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Fraile Moreno E, Cruz Díaz A. [Diagnostic imaging in liver pathology]. Rev Clin Esp 2005;205:97-8. [PMID: 15811274 DOI: 10.1157/13072963] [Reference Citation Analysis]
28 Macarini L, Milillo P, Cascavilla A, Scalzo G, Stoppino L, Vinci R, Moretti G, Ettorre G. MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers. Radiol med 2009;114:1267-82. [DOI: 10.1007/s11547-009-0464-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
29 Yoo HJ, Lee JM, Lee MW, Kim SJ, Lee JY, Han JK, Choi BI. Hepatocellular Carcinoma in Cirrhotic Liver: Double-Contrast-Enhanced, High-Resolution 3.0T-MR Imaging With Pathologic Correlation: . Investigative Radiology 2008;43:538-46. [DOI: 10.1097/rli.0b013e3181768d96] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
30 Lopresto V, Pinto R, Farina L, Cavagnaro M. Treatment planning in microwave thermal ablation: clinical gaps and recent research advances. Int J Hyperthermia 2017;33:83-100. [PMID: 27431328 DOI: 10.1080/02656736.2016.1214883] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
31 Sun R, Dittrich J, Le-Huu M, Mueller MM, Bedke J, Kartenbeck J, Lehmann WD, Krueger R, Bock M, Huss R, Seliger C, Gröne HJ, Misselwitz B, Semmler W, Kiessling F. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison. Invest Radiol 2005;40:504-13. [PMID: 16024988 DOI: 10.1097/01.rli.0000162925.26703.3a] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 4.2] [Reference Citation Analysis]
32 Guiu B, Loffroy R, Ben Salem D, Lepage C, Guiu S, Aho S, Jouve JL, Krausé D, Cercueil JP. Combined SPIO-gadolinium magnetic resonance imaging in cirrhotic patients: negative predictive value and role in screening for hepatocellular carcinoma. Abdom Imaging 2008;33:520-8. [PMID: 17912584 DOI: 10.1007/s00261-007-9327-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
33 Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology. 2005;237:520-528. [PMID: 16192317 DOI: 10.1148/radiol.2372041183] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
34 Scharitzer M, Ba-Ssalamah A, Ringl H, Kölblinger C, Grünberger T, Weber M, Schima W. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol. 2013;23:2187-2196. [PMID: 23519439 DOI: 10.1007/s00330-013-2824-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 8.0] [Reference Citation Analysis]
35 Bonnemain B. [Nanoparticles: the industrial viewpoint. Applications in diagnostic imaging]. Ann Pharm Fr 2008;66:263-7. [PMID: 19061725 DOI: 10.1016/j.pharma.2008.07.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
36 Cordin J, Lehmann K, Schneider PM. Clinical Staging of Adenocarcinoma of the Esophagogastric Junction. In: Schneider PM, editor. Adenocarcinoma of the Esophagogastric Junction. Berlin: Springer Berlin Heidelberg; 2010. pp. 73-83. [DOI: 10.1007/978-3-540-70579-6_6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
37 Hussain SM, Semelka RC. Liver masses. Magn Reson Imaging Clin N Am. 2005;13:255-275. [PMID: 15935311 DOI: 10.1016/j.mric.2005.03.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
38 Kim Y, Kim C, Han Y, Park G, Hwang S, Yu H. Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma. Clinical Radiology 2010;65:358-65. [DOI: 10.1016/j.crad.2009.11.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
39 Hekimoglu K, Ustundag Y, Dusak A, Kalaycioglu B, Besir H, Engin H, Erdem O. Small colorectal liver metastases: detection with SPIO-enhanced MRI in comparison with gadobenate dimeglumine-enhanced MRI and CT imaging. Eur J Radiol 2011;77:468-72. [PMID: 19781882 DOI: 10.1016/j.ejrad.2009.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
40 Low RN. Abdominal MRI advances in the detection of liver tumours and characterisation. Lancet Oncol. 2007;8:525-535. [PMID: 17540304 DOI: 10.1016/S1470-2045(07)70170-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
41 Kim YK, Kim CS, Han YM. Detection of small hepatocellular carcinoma: comparison of conventional gadolinium-enhanced MRI with gadolinium-enhanced MRI after the administration of ferucarbotran. Br J Radiol. 2009;82:468-484. [PMID: 19124563 DOI: 10.1259/bjr/76535286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
42 Heilmaier C, Lutz AM, Bolog N, Weishaupt D, Seifert B, Willmann JK. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging. Radiology 2009;253:724-33. [PMID: 19789232 DOI: 10.1148/radiol.2533090161] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
43 Guiu B, Loffroy R, Cercueil J. Double-Contrast MRI in Patients with Cirrhosis. American Journal of Roentgenology 2008;191:W78-W78. [DOI: 10.2214/ajr.07.3872] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Ward J, Robinson PJ, Guthrie JA, Downing S, Wilson D, Lodge JP, Prasad KR, Toogood GJ, Wyatt JI. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology. 2005;237:170-180. [PMID: 16126930 DOI: 10.1148/radiol.2371041444] [Cited by in Crossref: 118] [Cited by in F6Publishing: 97] [Article Influence: 6.9] [Reference Citation Analysis]
45 Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA. Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement. Ann Surg Oncol 2006;13:1261-8. [DOI: 10.1245/s10434-006-9023-y] [Cited by in Crossref: 218] [Cited by in F6Publishing: 188] [Article Influence: 13.6] [Reference Citation Analysis]
46 Stroszczynski C, Gaffke G, Gnauck M, Streitparth F, Wieners G, Lopez-Häninnen E. [Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA]. Radiologe 2004;44:1185-91. [PMID: 15549226 DOI: 10.1007/s00117-004-1134-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
47 Clasen S, Pereira PL. Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging. 2008;27:421-433. [PMID: 18219677 DOI: 10.1002/jmri.21264] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 5.8] [Reference Citation Analysis]
48 Kim YK, Lee YH, Kwak HS, Kim CS, Han YM. Small malignant hepatic tumor detection in gadolinium- and ferucarbotran-enhanced magnetic resonance imaging: does combining ferucarbotran-enhanced T2*-weighted gradient echo and T2-weighted turbo spin echo images have additive efficacy? Korean J Radiol 2008;9:510-9. [PMID: 19039267 DOI: 10.3348/kjr.2008.9.6.510] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
49 Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR. An evaluation of the sensitivity of MRI at detecting hepatocellular carcinoma in cirrhotic patients utilizing an explant reference standard. Clinical Imaging 2014;38:693-7. [DOI: 10.1016/j.clinimag.2014.05.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
50 Hanna RF, Kased N, Kwan SW, Gamst AC, Santosa AC, Hassanein T, Sirlin CB. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. AJR Am J Roentgenol. 2008;190:47-57. [PMID: 18094293 DOI: 10.2214/ajr.07.2595] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
51 Kudo M. Diagnostic imaging of hepatocellular carcinoma: Recent progress. Oncology. 2011;81 Suppl 1:73-85. [PMID: 22212940 DOI: 10.1159/000333265] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
52 Lee DH, Kim SH, Lee JM, Park HS, Lee JY, Yi NJ, Suh KS, Jang JJ, Han JK, Choi BI. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings. Invest Radiol 2009;44:311-21. [PMID: 19462486 DOI: 10.1097/rli.0b013e31819c9f44] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
53 Kim SH, Choi D, Kim SH, Lim JH, Lee WJ, Kim MJ, Lim HK, Lee SJ. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2005;184:1069-1076. [PMID: 15788575 DOI: 10.2214/ajr.184.4.01841069] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
54 Lee HY, Lee JM, Kim SH, Shin KS, Lee JY, Han JK, Choi BI. Detection and characterization of focal hepatic lesions: comparative study of MDCT and gadobenate dimeglumine-enhanced MR imaging. Clin Imaging 2008;32:287-95. [PMID: 18603184 DOI: 10.1016/j.clinimag.2007.11.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
55 Cantisani V, Grazhdani H, Fioravanti C, Rosignuolo M, Calliada F, Messineo D, Bernieri MG, Redler A, Catalano C, D’Ambrosio F. Liver metastases: Contrast-enhanced ultrasound compared with computed tomography and magnetic resonance. World J Gastroenterol 2014; 20(29): 9998-10007 [PMID: 25110428 DOI: 10.3748/wjg.v20.i29.9998] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]